Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety and tolerability of intranasal insulin in
people with type 1 diabetes and diabetic peripheral neuropathy and to determine whether
intranasal insulin is effective in slowing the progression of diabetic neuropathy.